Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00033033
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2002-04-05
Brief Title:
Reserpine for the Treatment of Cocaine Dependence - 1
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Phase 2 Double-Blind Placebo-Controlled Trial of Reserpine for the Treatment of Cocaine Dependence
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the efficacy and safety of reserpine for the treatment of cocaine dependence
Detailed Description:
To assess the efficacy and safety of reserpine in reducing cocaine use in subjects with cocaine dependence This is a double-blind placebo-controlled parallel-group design with a 2 week baseline period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None